Wednesday, July 8, 2026

biotech · Chronic Peripheral Neuropathy Pain in Diabetics · Diabetic Peripheral Neuropathy · XTLB

XTL BIOPHARMACEUTICALS

XTL BIOPHARMACEUTICALS trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

Raanana, USA HQ
1993 Founded
3 Employees
Public company Type
XTLB · NYSE Ticker
Company details
Status
Public
HQ
Raanana, USA
Founded
1993
Employees
3
Programs
4
Drugs
1
Patents
7
Intelligence · Clinical Trials

XTL BIOPHARMACEUTICALS clinical trials

Registry index of 4 ClinicalTrials.gov studies linked to XTL BIOPHARMACEUTICALS programs — each row shows trial ID, program name, phase, status, and indication.

XTL BIOPHARMACEUTICALS trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

4 updates

Latest clinical program signals indexed for XTL BIOPHARMACEUTICALS.

  1. XTL 6865 — Phase 1

    Clinical update
  2. Bicifadine — Phase 2

    Clinical update
  3. Bicifadine — Phase 2

    Clinical update
  4. XTL-2125 — Phase 1

    Clinical update

Trial registry

4 studies